Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022

Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million. This is a decrease from Q4 2021’s $217.8 million but an increase from Q1 2021’s $178.4 million.

“While our 10-state footprint saw a cumulative sequential contraction of 4.5%, we held or took market share in most of our states and outperformed the markets with our 2% decline,” said CEO Charles Bachtell.

However, the firm still ended with a net loss of $23.7 million compared to the net losses of $11.9 million and $24.1 million last quarter and last year, respectively.

Calibrating for financial items, adjusted EBITDA for the year ended at $50.7 million, a decrease from last quarter’s $57.0 million (which itself includes an adjustment for a $14.9 million impairment loss) but an increase from last year’s $35.0 million.

The firm ended Q1 2022 with $181.9 million in cash, cash equivalents, and restricted cash balance coming from a starting balance of $226.1 million at the beginning of the quarter. The cash burn is mainly due to spending in investing activities at $34.2 million.

Cresco Labs last traded at $5.00 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Cresco Labs Records Q3 Revenues of $215.5 Million, Impairs $290.9 Million In Assets

Cresco Labs (CSE: CL) reported its third quarter financial results this morning, reporting marginal revenue...

Thursday, November 11, 2021, 07:54:22 AM

Cresco Labs Reports $215 Million Net Loss For 2022

Cresco Labs (CSE: CL) saw its revenues in 2022 increase 3% over the prior year....

Thursday, March 16, 2023, 09:57:10 AM

US Cannabis: Stifel Expects “Limited To No Sales Growth”

Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the...

Monday, August 1, 2022, 01:17:00 PM

Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition

Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia...

Friday, July 15, 2022, 08:09:23 AM

P Diddy To Spend $185 Million Acquiring Cannabis Assets From Cresco Labs, Columbia Care

Cresco Labs (CSE: CL) appears to be monetizing the appointment of director Tarik Brooks, which...

Friday, November 4, 2022, 08:44:11 AM